Psychosocial treatments for women with substance use disorders

Obstetrics and Gynecology Clinics of North America

Volumn 30, Issue 3, 2003, Pages 483-499

  Winhusen, Theresa M ^a,b   Kropp, Frankie ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; OPIATE;

ALCOHOLISM; BEHAVIOR MODIFICATION; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; FEMALE; GROUP THERAPY; HEALTH CARE UTILIZATION; HUMAN; MEDICAL RESEARCH; MOTIVATION; MOTIVATIONAL ENHANCEMENT THERAPY; OUTCOMES RESEARCH; PATIENT COUNSELING; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REVIEW; SEX DIFFERENCE; SEX RATIO; SKILL; SUBSTANCE ABUSE; TREATMENT FAILURE;

EID: 0242404531     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(03)00069-X     Document Type: Review

References (87)

1. Crits-Christoph P, Siqueland L. Psychosocial treatment for drug abuse. Selected review and recommendations for National Health Care. Arch Gen Psychiatry 1996;53:749-56.
2. Stark MJ. Dropping out of substance abuse treatment: a clinically oriented review. Clin Psychol Rev 1992;12:93-116.
3. Grella CE. Women in residential drug treatment: differences by program type and pregnancy. J Health Care Poor Underserved 1999;10(2):216-29.
4. Mertens JR, Weisner CM. Predictors of substance abuse treatment retention among women and men in an HMO. Alcohol Clin Exp Res 2000;24(10):1525-33.
5. Green CA, Polen MR, Dickinson DM, Lynch FL, Bennett MD. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. J Subst Abuse Treat 2002;23(4):285-95.
6. Harrison PA, Asche SE. Comparison of substance abuse treatment outcomes for inpatients and outpatients. J Subst Abuse Treat 1999;17(3):207-20.
7. Greenwood GL, Woods WJ, Guydish J, Bein E. Relapse outcomes in a randomized trial of residential and day drug abuse treatment. J Subst Abuse Treat 2001;20:15-23.
8. Compton WM, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry 2003;160:890-5.
9. Agosti V, Nunes E, Stewart JW, Quitkin FM. Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report. Int J Addict 1991;26(3):327-34.
10. Greenfield SF, Kolodziej ME, Sugarman DE, Muenz LR, Vagge LM, He DY, et al. History of abuse and drinking outcomes following inpatient alcohol treatment: a prospective study. Drug Alcohol Depend 2002;67:227-34.
11. Cosden M, Cortez-Ison E. Sexual abuse, parental bonding, social support, and program retention for women in substance abuse treatment. J Subst Abuse Treat 1999;16(2):149-55.
12. Tuten M, Jones HE. A partner's drug-using status impacts women's drug treatment outcome. Drug Alcohol Depend 2003;70:327-30.
13. Cornelius JR, Jarrett PJ, Thase ME, Fabrega Jr H, Haas GL, Jones-Barlock A, et al. Gender effects on the clinical presentation of alcoholics at a psychiatric hospital. Compr Psychiatry 1995;36(6): 435-40.
14. Fiorentine R, Anglin MD, Gil-Rivals V, Taylor E. Drug treatment: explaining the gender paradox. Subst Use Misuse 1997;32(6):653-78.
15. Griffin ML, Weiss RD, Mirin SM, Lange U. A comparison of male and female cocaine abusers. Arch Gen Psychiatry 1989;46:122-6.
16. Magura S, Kang SY, Rosenblum A, Handelsman L, Foote J. Gender differences in psychiatric comorbidity among cocaine-using opiate addicts. J Addict Dis 1998;17(3):49-61.
17. McCance-Katz EF, Carroll KM, Rounsaville BJ. Gender differences in treatment-seeking cocaine abusers-implications for treatment and prognosis. Am J Addict 1999;8:300-11.
18. Pelissier BMM, Camp SD, Gaes GG, Saylor WG, Rhodes W. Gender differences in outcomes from prison-based residential treatment. J Subst Abuse Treat 2003;24:149-60.
19. Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982;39:161-6.
20. Lundy A, Gottheil E, Serota RD, Weinstein SP, Sterling RC. Gender differences and similarities in African-American crack cocaine users. J Nerv Ment Dis 1995;183:260-6.
21. Brady KT, Grice DE, Dustan L, Randall C. Gender differences in substance use disorders. Am J Psychiatry 1993;150(11):1707-11.
22. Kosten TA, Gawin FH, Kosten TR, Rounsaville BJ. Gender differences in cocaine use and treatment response. J Subst Abuse Treat 1993;10:63-6.
23. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 1991;48:43-51.
24. Weiss RD, Martinez-Raga J, Griffin ML, Greenfield SF, Hufford C. Gender differences in cocaine dependent patients: a 6 month follow-up study. Drug Alcohol Depend 1997;44:35-40.
25. Anglin MD, Hser Y-I, Booth MW. Sex differences in addict careers. 4. Treatment. Am J Drug Alcohol Abuse 1987;13(3):253-80.
26. Callaghan RC, Cunningham JA. Gender differences in detoxification: predictors of completion and re-admission. J Subst Abuse Treat 2002;23:399-407.
27. Denier CA, Thevos AK, Latham PK, Randall CL. Psychosocial and psychopathology differences in hospitalized male and female cocaine abusers: a retrospective chart review. Addict Behav 1991;16:489-96.
28. Arfken CL, Klein C, diMenza S, Schuster CR. Gender differences in problem severity at assessment and treatment retention. J Subst Abuse Treat 2001;20:53-7.
29. Weisner C, Schmidt L. Gender disparities in treatment for alcohol problems. JAMA 1992;268(14): 1872-6.
30. Dudish SA, Hatsukami DK. Gender differences in crack users who are research volunteers. Drug Alcohol Depend 1996;42:55-63.
31. Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 1985;42:1050-5.
32. Najavits LM, Gastfriend DR, Barber JP, Reif S, Muenz LR, Blaine J, et al. Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Am J Psychiatry 1998;155(2):214-9.
33. Wallen J. A comparison of male and female clients in substance abuse treatment. J Subst Abuse Treat 1992;9:243-8.
34. Dansky BS, Brady KT, Saladin ME, Killeen T, Becker S, Roitzsch J. Victimization and PTSD in individuals with substance use disorders: gender and racial differences. Am J Drug Alcohol Abuse 1996;22(1):75-93.
35. O'Hare T. Mental health problems and alcohol abuse: co-occurrence and gender differences. Health Soc Work 1995;20(3):207-14.
36. Brown TG, Kokin M, Seraganian P. Shields N. The role of spouses of substance abusers in treatment: gender differences. J Psychoactive Drugs 1995;27(3):223-9.
37. Blume S. Sexuality and stigma. The alcoholic woman. Alcohol Health Res World 1991;15(2): 139-46.
38. Jarvis TJ. Implications of gender for alcohol treatment research: a quantitative and qualitative review. Br J Addict 1992;87:1249-61.
39. Toneatto A, Sobell LC, Sobell MB. Gender issues in the treatment of abusers of alcohol, nicotine, and other drugs. J Subst Abuse 1992;4:209-18.
40. Timko C, Moos RH, Finney JW, Connell EG. Gender differences in help-utilization and the 8 year course of alcohol abuse. Addiction 2002;97:877-89.
41. Alterman A, Randall M, McLellan AT. Comparison of outcomes by gender and for fee-for-service versus managed care: a study of nine community programs. J Subst Abuse Treat 2000;19:127-34.
42. Oggins J, Guydish J, Delucchi K. Gender differences in income after substance abuse treatment. J Subst Abuse Treat 2001;20:215-24.
43. Rowan-Szal GA, Chatham LR, Joe GW, Simpson DD. Services provided during methadone treatment: a gender comparison. J Subst Abuse Treat 2000;19:7-14.
44. Stitzer ML, Bickel WK, Bigelow GE, Liebson IA. Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients. Drug Alcohol Depend 1986;18:341-8.
45. Iguchi MY, Stitzer ML, Bigelow GE, Liebson IA. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug Alcohol Depend 1988;22:1-7.
46. Stitzer ML, Iguchi MY, Felch LJ. Contingent take-home incentive: effects on drug use of methadone maintenance patients. J Consult Clin Psychol 1992;60(6):927-34.
47. Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend 1999;54:127-35.
48. Carroll KM, Ball SA, Nich C, O'Connor PG, Eagan DA, Frankforter TL, et al. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence. Arch Gen Psychiatry 2001;58:755-61.
49. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 1994;51:568-76.
50. Tidey JW, Mehl-Madrona L, Higgins ST, Badger GJ. Psychiatric symptom severity in cocaine-dependent outpatients: demographics, drug use characteristics and treatment outcome. Drug Alcohol Depend 1998;50:9-17.
51. McCrady BS, Noel NE, Abrams DB, Stout RL, Nelson HF, Hay WM. Comparative effectiveness of three types of spouse involvement in outpatient behavioral alcoholism treatment. J Stud Alcohol 1986;47(6):459-67.
52. Eriksen L, Bjomstad S, Gotestam KG. Social skills training in groups for alcoholics: one-year treatment outcome for groups and individuals. Addict Behav 1986;11:309-29.
53. Kadden RM, Cooney NL, Getter H, Litt MD. Matching alcoholics to coping skills or interactional therapies: Posttreatment results. J Consult Clin Psychol 1989;6:698-704.
54. Rohsenow DJ, Monti PM, Martin RA, Michalee E, Abrams DB. Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes. J Consult Clin Psychol 2000;68(3):515-20.
55. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 1997;58:7-29.
56. Project MATCH Research Group. Project MATCH secondary a priori hypotheses. Addiction 1997;92(12):1671-98.
57. Ferrell WL, Galassi JP. Assertion training and human relations training in the treatment of chronic alcoholics. Int J Addict 1981;16(5):959-68.
58. Sanchez-Craig M, Annis HM, Bornet AR, MacDonald KR. Random assignment to abstinence and controlled drinking: evaluation of a cognitive-behavioral program for problem drinkers. J Consult Clin Psychol 1984;52(3):390-403.
59. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Arch Gen Psychiatry 1994;51:989-97.
60. Stephens RS, Roffman RA, Simpson EE. Treating adult marijuana dependence: a test of the relapse prevention model. J Consult Clin Psychol 1994;62:92-9.
61. Wells EA, Peterson PL, Gainey RR, Hawkins JD, Catalano RF. Outpatient treatment for cocaine abuse: a controlled comparison of relapse prevention and twelve-step approaches. Am J Drug Alcohol Abuse 1994;20(1):1-17.
62. Saunders B, Wilkinson C, Phillips M. The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction 1995;90:415-24.
63. Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, et al. Psychosocial treatments for cocaine dependence. National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry 1999;56:493-502.
64. Svikis D, Lee JH, Haug NA, Stitzer ML. Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Depend 1997;48:33-41.
65. Jones HE, Haug NA, Stitzer ML, Svikis DS. Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives. Addict Behav 2000;25(2):263-7.
66. Jones HE, Haug N, Silverman K, Stitzer M, Svikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug Alcohol Depend 2001;61:297-306.
67. Handmaker NS, Miller WR, Manicke M. Findings of a pilot study of motivational interviewing with pregnant drinkers. J Stud Alcohol 1999;60:285-7.
68. Hubbard RL, Marsden ME. Relapse to use of heroin, cocaine, and other drugs in the first year after treatment. In: Leukefeld CG, Tims FM, editors. Relapse and recovery in drug abuse. Rockville, MD: Department of Health and Human Services; 1986. p. 157-66. NIDA Research Monograph 72.
69. Green CA, Pope CR. Gender, psychosocial factors and the use of medical services: a longitudinal analysis. Soc Sci Med 1999;48:1363-72.
70. Lewis RA, Haller DL, Branch D, Ingersoll K. Retention issues involving drug abusing women in treatment research. Rockville, MD: National Institute on Drug Abuse; 1996. p. 110-22. NIDA Research Monograph 165.
71. Hodgins DC, El-Guebaly N, Addington J. Treatment of substance abusers: single or mixed gender programs? Addiction 1997;92(7):805-12.
72. Copeland J, Hall W, Didcott P, Biggs V. A comparison of a specialist women's alcohol and other drug treatment service with two traditional mixed-sex services: client characteristics and treatment outcome. Drug Alcohol Depend 1993;32:81-2.
73. Najavits LM, Weiss RD, Liese BS. Group cognitive-behavioral therapy for women with PTSD and substance use disorder. J Subst Abuse Treat 1996;13(1):13-22.
74. Volpicelli JR, Markman I, Monterosso J, Filing J, O'Brien CP. Psychosocially enhanced treatment for cocaine-dependent mothers. Evidence of efficacy. J Subst Abuse Treat 2000;18:41-9.
75. Sterling RC, Gottheil E, Weinstein SP, Serota R. Therapist/patient race and sex matching: treatment retention and 9-month follow-up outcome. Addiction 1998;93(7):1043-50.
76. Sterling RC, Gottheil E, Weinstein SP, Serota R. The effect of therapist/patient race- and sex-matching in individual treatment. Addiction 2001;96(7):1015-22.
77. Condelli WS, Koch MA, Fletcher B. Treatment refusal/attrition among adults randomly assigned to programs at a drug treatment campus. The New Jersey Substance Abuse Treatment Campus, Seacucus, NJ. J Subst Abuse Treat 2000;18:395-407.
78. Hughes PH, Coletti SD, Neri RL, Urmann CF, Stahl S, Sicilian DM, et al. Retaining cocaine-abusing women in a therapeutic community: The effect of a child live-in program. Am J Public Health 1995;85(8):1149-52.
79. Najavits LM. Clinicians' view on treating posttraumatic stress disorder and substance use disorder. J Subst Abuse Treat 2002;22:79-85.
80. Najavits LM, Weiss RD, Shaw SR, Muenz LR. Seeking safety: outcome of a new cognitive-behavioral psychotherapy for women with posttraumatic stress disorder and substance dependence. J Trauma Stress 1998;11(3):437-56.
81. Hien DA, Cohen LR, Miele GM, Litt LC, Capstick C. Promising empirically supported treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry, in press.
82. Dahlgren L, Willander A. Are special treatment facilities for female alcoholics needed? A controlled 2-year follow-up study from a specialized female unit (EWA) versus a mixed male/female treatment facility. Alcohol Clin Exp Res 1989;13(4):499-504.
83. Strantz IH, Welch SP. Postpartum women in outpatient drug abuse treatment: correlates of retention/completion. J Psychoactive Drugs 1995;27(4):357-73.
84. Howell EM, Heiser N, Harrington M. A review of recent findings on substance abuse treatment for pregnant women. J Subst Abuse Treat 1999;16(3):195-219.
85. Frank E, Thase ME, Spanier CA, Reynolds CF, Kupfer DJ. Gender-specific response to depression treatment. J Gend Specif Med 1999;2(4):40-4.
86. Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatr Clin North Am 1999;22(2):241-52.
87. Kumpfer KL. Outcome measures of interventions in the study of children of substance-abusing parents. Pediatrics 1999;103:1128-44.